title: Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
authors.forename: Florent
authors.initials: F
authors.lastname: Grange
authors.forename: Eve
authors.initials: E
authors.lastname: Maubec
authors.forename: Martine
authors.initials: M
authors.lastname: Bagot
authors.forename: Marie
authors.initials: M
authors.lastname: Beylot-Barry
authors.forename: Pascal
authors.initials: P
authors.lastname: Joly
authors.forename: Stéphane
authors.initials: S
authors.lastname: Dalle
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Delaporte
authors.forename: Olivier
authors.initials: O
authors.lastname: Dereure
authors.forename: Hervé
authors.initials: H
authors.lastname: Bachelez
authors.forename: Béatrice
authors.initials: B
authors.lastname: Vergier
authors.forename: Tony
authors.initials: T
authors.lastname: Petrella
authors.forename: Michel
authors.initials: M
authors.lastname: D'Incan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007866:Leg; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D012878:Skin Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone